Brought to you by 
Genoptix completes $74.9mm IPO
06 Nov 2007
Executive Summary
Genoptix Inc. (also known as Genoptix Medical Laboratory; performs genetic testing services for cancer diagnostics) netted $74.9mm through its initial public offering of 4.73mm common shares (including the overallotment) at $17 each, higher than the company's anticipated range of $14-16. Selling stockholders also sold about 1mm shares.
Deal Industry
- In Vitro Diagnostics
- Laboratory Testing Services
- Pharmaceuticals
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Genoptix completes $74.9mm IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice